UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 270

Sortiert nach

Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia

Harm reduction journal, 2023-01, Vol.20 (1), p.9-13, Article 9

2023

Volltextzugriff (PDF)

Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond

Journal of hepatology, 2018-03, Vol.68 (3), p.383-385

2018

Volltextzugriff (PDF)

Constructing a ‘target population’: A critical analysis of public health discourse on substance use among gay and bisexual men, 2000–2020

The International journal of drug policy, 2022-10, Vol.108, p.103808-103808, Article 103808

2022

Volltextzugriff (PDF)

Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department

The International journal of drug policy, 2019-10, Vol.72, p.84-90

2019

Volltextzugriff (PDF)

Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol

BMJ open, 2022-03, Vol.12 (3), p.e056120-e056120

2022

Volltextzugriff (PDF)

Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study)

BMJ open, 2022-01, Vol.12 (1), p.e057618

2022

Volltextzugriff (PDF)

Reaching hepatitis C virus elimination targets in Australia requires use of complementary cost-effective interventions along the care cascade

Journal of hepatology, 2017, Vol.66 (1), p.S413-S413

2017

Volltextzugriff (PDF)

A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol

BMC infectious diseases, 2016-12, Vol.16 (1), p.752-752, Article 752

2016

Volltextzugriff (PDF)

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

The lancet. Gastroenterology & hepatology, 2019-02, Vol.4 (2), p.135-184

2019

Volltextzugriff (PDF)

O15 Recommendations for hepatitis C virus testing among people who inject drugs in Australia

Journal of Virus Eradication, 2017-08, Vol.3, p.6

2017

Volltextzugriff (PDF)

P59 Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade

Journal of Virus Eradication, 2017-08, Vol.3, p.32

2017

Volltextzugriff (PDF)

O17 Eliminate Hepatitis C Partnership: clinical site scoping

Journal of Virus Eradication, 2017-08, Vol.3, p.7

2017

Volltextzugriff (PDF)

Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade

The International journal of drug policy, 2017-09, Vol.47, p.107-116

2017

Volltextzugriff (PDF)

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

International journal of epidemiology, 2024-02, Vol.53 (1)

2024

Volltextzugriff (PDF)

P48 Implementing an elimination program for hepatitis C: a partnership approach from Victoria

Journal of Virus Eradication, 2017-08, Vol.3, p.28

2017

Volltextzugriff (PDF)

128 HEPATITIS C INFECTION, CLEARANCE AND REINFECTION IN A COHORT OF INJECTING DRUG USERS – A HIGHLY DYNAMIC PROCESS

Journal of hepatology, 2010, Vol.52, p.S57-S57

2010

Volltextzugriff (PDF)

Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study

The International journal of drug policy, 2019-10, Vol.72, p.91-98

2019

Volltextzugriff (PDF)

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

The lancet HIV, 2024-02, Vol.11 (2), p.e106-e116

2024

Volltextzugriff (PDF)

THU-052 - Heterogeneity in hepatitis C virus treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

Journal of hepatology, 2018-04, Vol.68, p.S145-S145

2018

Volltextzugriff (PDF)

Heterogeneity in hepatitis C virus treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

Journal of hepatology, 2018-04, Vol.68, p.S145

2018

Volltextzugriff (PDF)

Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility

The International journal of drug policy, 2024-03, Vol.125, p.104317-104317, Article 104317

2024

Volltextzugriff (PDF)

FRI-475 - Reaching hepatitis C virus elimination targets in Australia requires use of complementary cost-effective interventions along the care cascade

Journal of hepatology, 2017, Vol.66 (1), p.S413-S413

2017

Volltextzugriff (PDF)

Joint statement in support of hepatitis C human challenge studies

The lancet. Gastroenterology & hepatology, 2023-11, Vol.8 (11), p.967-969

2023

Volltextzugriff (PDF)

The Rapid-EC study – A feasibility study of point-of-care testing in community clinics targeted to people who inject drugs in Melbourne, Australia

Journal of hepatology, 2018-04, Vol.68, p.S313-S314

2018

Volltextzugriff (PDF)

THU-405 - The Rapid-EC study – A feasibility study of point-of-care testing in community clinics targeted to people who inject drugs in Melbourne, Australia

Journal of hepatology, 2018-04, Vol.68, p.S313-S314

2018

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(239)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(169)
Humans
(93)
Male
(59)
Hepatitis C
(54)
Infectious Diseases
(50)
Female
(42)
Public Health
(40)
Adult
(39)
Public, Environmental & Occupational Health
(37)
Hiv
(34)
Hepatitis
(32)
Human Immunodeficiency Virus
(29)
Gastroenterology & Hepatology
(27)
Hepatitis C - Epidemiology
(26)
Infections
(25)
Australia - Epidemiology
(23)
Hepatitis C - Drug Therapy
(23)
Middle Aged
(23)
Health Services
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia

Achieving hepatitis C elimination in Europe – To treatment scale-up and beyond

Constructing a ‘target population’: A critical analysis of public health discourse on substance use among gay and bisexual men, 2000–2020

Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department

Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol

Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study)

Reaching hepatitis C virus elimination targets in Australia requires use of complementary cost-effective interventions along the care cascade

A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

O15 Recommendations for hepatitis C virus testing among people who inject drugs in Australia

P59 Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade

O17 Eliminate Hepatitis C Partnership: clinical site scoping

Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

P48 Implementing an elimination program for hepatitis C: a partnership approach from Victoria

128 HEPATITIS C INFECTION, CLEARANCE AND REINFECTION IN A COHORT OF INJECTING DRUG USERS – A HIGHLY DYNAMIC PROCESS

Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

THU-052 - Heterogeneity in hepatitis C virus treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

Heterogeneity in hepatitis C virus treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility

FRI-475 - Reaching hepatitis C virus elimination targets in Australia requires use of complementary cost-effective interventions along the care cascade

Joint statement in support of hepatitis C human challenge studies

The Rapid-EC study – A feasibility study of point-of-care testing in community clinics targeted to people who inject drugs in Melbourne, Australia

THU-405 - The Rapid-EC study – A feasibility study of point-of-care testing in community clinics targeted to people who inject drugs in Melbourne, Australia

Aktive Filter

Suchergebnisse filtern